SCHEMBL15744180

SCHEMBL15744180

N=C(F)c1cc(Br)ccc1N

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.57
GLA P06280 1/20 0.57
MAPT P10636 4/20 0.50
POLB P06746 1/20 0.50
PLAU P00749 2/20 0.49
MAPK1 P28482 2/20 0.39
NPC1 O15118 1/20 0.39
HTT P42858 1/20 0.39
DGAT1 O75907 1/20 0.37
ALOX15 P16050 3/20 0.36
CES2 O00748 1/20 0.36
GALR3 O60755 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
CASP1 P29466 1/20 0.36
CYP2C19 P33261 1/20 0.36
GPR35 Q9HC97 2/20 0.36
C1S P09871 1/20 0.35
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23992891 0.83 KDM4E (0.42) KDM4EGLAMAPTPOLBPLAU
SCHEMBL15248274 0.79 KDM4E (0.57) KDM4EGLAMAPTPOLBPLAU
SCHEMBL17177294 0.79 KDM4E (0.57) KDM4EGLAMAPTPOLBPLAU
SCHEMBL6707733 0.78 KDM4E (0.55) KDM4EGLAMAPTPOLBPLAU
SCHEMBL20204052 0.75 KEAP1 (0.34) KDM4EGLAMAPTPOLBKMT2A
SCHEMBL19688933 0.75 KDM4E (0.56) KDM4EGLAMAPTPOLBPLAU
SCHEMBL16109488 0.75 MAPT (0.69) KDM4EGLAMAPTPOLBPLAU
SCHEMBL24147311 0.75 KDM4E (0.52) KDM4EGLAMAPTPOLBPLAU
SCHEMBL18971880 0.75 KDM4E (0.67) KDM4EGLAMAPTPOLBPLAU
SCHEMBL23236602 0.73 KDM4E (0.50) KDM4EGLAMAPTPOLBPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022150574-A1 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE CORNELL UNIVERSITY (US) 2022-07-14 WO disclosed
EP-2735562-A1 Estrogen receptor modulators and uses thereof Seragon Pharmaceuticals, Inc. (US) 2014-05-28 EP disclosed